Try our Advanced Search for more refined results
7,976,838
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-.alpha. inhibitor
- July 31, 2018 Trends And Predictions For Serial Biologic Drug IPR Petitions
- April 05, 2018 Sandoz Rehashed Arguments In Rituxan IP Challenge: PTAB
- August 21, 2015 The 1st IPR Institution Decisions For Biosimilars
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login